Rebooting the immune system

Israel’s NeoTX (see here previously) is now conducting a Phase 2 trial of its naptumomab estafenatox (NAP) bacteria-coated, immunotherapy cancer treatment on 30 patients in the US. It is also enhancing an AstraZeneca checkpoint inhibitor. NeoTX has 3 Nobel prizewinners in its team.

https://www.israel21c.org/new-cancer-treatment-fools-the-immune-system-to-attack/

https://finance.yahoo.com/news/neotx-announces-successful-first-stage-120000979.html

https://www.youtube.com/watch?v=ntk8XsxVDi0

https://neotx.com/

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.